Home > Boards > US Listed > Biotechs > vTv Therapeutics (VTVT)

So I didn’t delve too deeply into diabetes study

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
McMagyar Member Profile
 
Followed By 29
Posts 8,805
Boards Moderated 2
Alias Born 01/13/16
160x600 placeholder
vTv Therapeutics shares surge as TTP399 wins FDA 'Breakthrough Therapy' status Seeking Alpha - 4/13/2021 7:49:15 AM
Securities Registration Statement (simplified Form) (s-3) Edgar (US Regulatory) - 3/18/2021 4:31:45 PM
vTv Therapeutics starts TTP399 diabetes study Seeking Alpha - 3/18/2021 4:10:58 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 3/18/2021 7:37:05 AM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 3/18/2021 7:30:53 AM
Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) Edgar (US Regulatory) - 3/8/2021 4:18:38 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/2/2021 4:04:52 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/2/2021 4:04:15 PM
vTv Therapeutics EPS beats by $0.08, beats on revenue Seeking Alpha - 2/24/2021 4:59:27 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/24/2021 4:58:55 PM
vTv Therapeutics posts data from mid-stage TTP399 diabetes study Seeking Alpha - 2/23/2021 10:43:08 AM
Confidential Treatment Order (ct Order) Edgar (US Regulatory) - 2/18/2021 4:44:18 PM
vTv Therapeutics starts multiple ascending dose study of HPP737 as psoriasis treatment Seeking Alpha - 2/17/2021 4:23:29 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/21/2021 4:07:15 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/14/2021 5:16:00 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 1/14/2021 5:03:42 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/30/2020 4:30:58 PM
Amended Statement of Beneficial Ownership (sc 13d/a) Edgar (US Regulatory) - 12/17/2020 5:03:22 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/17/2020 5:02:50 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/17/2020 4:31:27 PM
Aditum Bio Announces Formation of Third Company, Anteris Bio PR Newswire (US) - 12/15/2020 9:05:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/15/2020 7:52:33 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/10/2020 4:46:19 PM
Amended Statement of Beneficial Ownership (sc 13d/a) Edgar (US Regulatory) - 12/10/2020 4:45:59 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/10/2020 4:31:34 PM
McMagyar   Tuesday, 06/11/19 02:40:41 PM
Re: None
Post # of 547 
So
I didn’t delve too deeply into diabetes study or results..
the market doesnt seem too excited..
VTVT first caught my attention with strata of Patients that responded in Alzheimer’s study...

I thought the numbers of their responding group in the AD were significant.. But...

Really the number one future medicine in AD profile is Anavex..
Maybe VTVt will be used as Adjuvant with A2/73.. but the market is saying by themselves VtVt’s drugs don’t pack enough punch..

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences